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Introduction: Rhinosinusitis is characterized by inflammation extending from the mucosa of the nasal cavity into
the paranasal sinuses. There are some aggravating features, such as immunosuppression, that can cause the nasal
mucosal inflammation to linger for a long period, resulting in chronic or recurrent episodes. Such
immunosuppression is the major feature of patients undergoing a hematopoietic stem cell transplant (HSCT);
rhinosinusitis prevalence is higher in this group compared to immunocompetent patients. Nasal epithelial
abnormalities have been described in, and may have some influence over, recurrent sinus infections among those
patients. However, it is not clear whether rhinosinusitis can trigger mucosal abnormalities or whether a preexisting
vulnerability for sinusitis recurrence is more likely. The objective of the study was to verify the influence of
rhinosinusitis on nasal epithelial damage in patients undergoing hematopoietic stem cell transplantation.
Method: A total of 30 allogeneic HSCT patients were divided into two groups: 24 patients with chronic or recurrent
rhinosinusitis and 6 patients without rhinosinusitis. These patients underwent a biopsy of the uncinate process that
was analyzed by transmission electron microscopy and optical microscopy.
Results: The nasal mucosa analysis by optical microscopy showed no significant abnormalities. The ciliary
orientation was obviously normal in the transplanted patients without rhinosinusitis. There was a trend toward a
difference in the amount of cilia (decreased) and the primary modification of the ultrastructure of transplanted
patients with rhinosinusitis.
Conclusion: HSCT patients, with and without rhinosinusitis, showed no significant histological abnormalities, except
for ciliary disorientation and a possible decrease in ciliary and ultrastructural abnormalities in HSCT patients with
rhinosinusitis.Introduction
Rhinosinusitis is characterized by inflammation extending
from the mucosa of the nasal cavity into the paranasal si-
nuses, blocking the sites of sinus drainage, especially the
middle meatus [1]. The uncinate process is a crucial ana-
tomical structure of the middle meatus, and its mucosa
may be representative of the paranasal sinuses [2,3]. Such
a blockage in the uncinate process region can trigger se-
cretion stasis within the maxillary, frontal and ethmoid* Correspondence: erica.ortiz@terra.com.br
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unless otherwise stated.sinuses, thus altering mucociliary clearance to favor the
possibility of microorganism proliferation and nasal mu-
cosa infections [1,3].
Certain aggravating factors can extend nasal mucosa
inflammation for longer periods, constituting chronic or
recurrent episodes [1,3]. Among the factors described in
the literature is immunosuppression, which constitutes
the main feature of patients undergoing hematopoietic
stem cell transplantation. The immunosuppression of
these patients is therefore believed to be the only cause
for their high frequency of rhinosinusitis [1,3-6].
The frequency of bacterial rhinosinusitis in patients
receiving hematopoietic stem cell transplants (HSCTs) is
much higher (37%) than that of immunocompetent pa-
tients (5 to 15%) [2,6-10]. The risk is further increasedhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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disease (GVHD), with a 4.3 times higher frequency of in-
fection. In addition, there is a risk of developing the
dreaded invasive fungal rhinosinusitis, although the fre-
quency of this type is lower (0.3 to 3.8%) [11-15].
Previous studies have shown histological and ultra-
structural abnormalities in the nasal mucosa of patients
with chronic GVHD undergoing HSCT compared with
immunocompetent patients, as described in Table 1.
This epithelial damage could be another causal feature
for the high prevalence of sinus infections in trans-
planted patients [16,17].
A subsequent study showed that there was no change
in the frequency of nasal epithelial damage in the pres-
ence of rhinosinusitis in patients undergoing HSCT,
even among those with GVHD. Immunosuppression
thus remains the main cause of the higher frequency of
rhinosinusitis in HSCT and GVHD [18].
Nevertheless, it seems that the recurrence of nasal in-
fection causes a progressive decrease in the number of
cilia in the sinus epithelia of transplanted patients [18].
Therefore, it is possible that epithelial damage could be
an associated or aggravated feature of sinusitis recur-
rence or chronicity.
Objective
Because transplanted patients have histological abnor-
malities after the hematopoietic stem cell transplantation
process, as well as in the presence of rhinosinusitis, and
because the recurrence of rhinosinusitis increases this
epithelial damage, the aim of this study is to verify the
influence of rhinosinusitis on nasal epithelial damage in pa-
tients undergoing hematopoietic stem cell transplantation.
Methods
This exploratory prospective study includes patients who
underwent a transplant of hematopoietic stem cells at
the Transplantation Hematopoietic Stem Cells Unit of
the HC UNICAMP/Blood Center of Campinas and who
were evaluated by the Office of Rhinology of Otorhino-
laryngology, FCM-UNICAMP, University of Campinas,Table 1 Histology of the nasal mucosa
HSCT
Cilia (absence or decrease) (%) 77
Ciliar ultrastructure abnormalities (%) 50
Cytoplasmic mitochondria (decreased/absence) (%) 80
Cytoplasmic vacuolization (%) 60
Apoptotic bodies 2.3
Goblet cells (decreased/absence), n (%) 2 (40%)
Moderate/severe inflammatory infiltrate, n (%) 13 (100%
Comparisons among patients undergoing hematopoietic stem cell transplant (HSCT
immunocompetent patients.Brazil. The study was approved by Research Ethics UNI-
CAMP, under number 088-2002, and patients also com-
pleted the research ethics consent form to participate in
this study.
We selected a total of 30 allogeneic hematopoietic
stem cell-transplanted patients who were divided into
two groups: 24 patients with chronic or recurrent rhino-
sinusitis, and six patients without rhinosinusitis. These
patients underwent a biopsy of the nose to collect the
samples; 24 patients underwent biopsies in the presence
of rhinosinusitis. Only 22 slides for the group with
rhinosinusitis were analyzable by electron microscopy,
and 19 slides were examined by optical microscopy (24
patients). The biopsies of the six patients without rhino-
sinusitis were analyzed by electron microscopy, and five
were examined by optical microscopy.
The rhinosinusitis diagnosis was made by clinical and
endoscopic nasal evaluation, according to the criteria of
the Brazilian Guidelines on Rhinosinusitis and a Euro-
pean Position Paper [1,2].
Exclusion criteria included patients with serious risks
of bleeding due to thrombocytopenia and patients with
cytomegalovirus or herpes virus.
Thirty patients, with an average age of 39 years and a
male predominance (63%), were transplanted with allo-
geneic hematopoietic stem cells. In total, 73% of these
patients underwent myeloablative transplantation and 27%
underwent nonmyeloablative transplantation. Table 2 pre-
sents the general characteristics of the groups of trans-
planted patients, with and without recurrent or chronic
rhinosinusitis.
Biopsies of the uncinate process mucosa at the middle
meatus were endoscopically performed for all patients
under anesthesia [15]. Those biopsies were taken from
the full thickness of the uncinate process of those patients
that underwent to surgery; and two or three samples from
the medial to lateral uncinate process, with cutting blaks-
ley. Histopathological evaluations were achieved using op-
tical microscopy and transmission electron microscopy.
Hematoxylin and eosin, Periodic acid–Schiff and Masson’s
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ALL: 1 (17%) With: 5 (83%)
CML: 3 (50%)
AML: 1 (17%) Without:
1 (17%)
AA: 1 (17%)
AA, aplastic anemia; ALL, acute lymphoblastic leukemia; AML, acute myeloid
leukemia; CLL, chronic lymphocytic leukemia; CML, chronic myeloid leukemia;
GVHD, graft versus host disease; HSCT, hematopoietic stem cell transplant;
MDS, myelodysplastic syndrome; MM, multiple myeloma; SCA, sickle
cell anemia.
Table 3 Analysis of the sinonasal epithelium by optical
microscopy
Light microscopy Without RS With RS P value
Moderate inflammatory infiltrate 0 7 (37%) 0.73
Intraepithelial lymphocytes (n/HPF) 1.14 12 0.073
Apoptotic bodies (n/HPF) 2.3 6.6 0.498
Eosinophils (n/HPF) 1.4 14.4 0.155
Glandular density (n/HPF) 8.6 11 0.227
Moderate/severe edema 0 3 (16%) 1
Fibrosis 0 31 (16%) 0.822
Basal membrane (mm) 0.019 0.048 0.347
Patients with transplanted hematopoietic stem cells, with and without
rhinosinusitis (RS). Fisher’s exact test and Wilcoxon analysis with P <0.05. n/
HPF = number per high-power field of greatest increase.
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copy of hematoxylin and eosin-stained samples were the
density and composition of the epithelial and submucosal
inflammatory infiltrate, the number of apoptotic bodies
and intraepithelial eosinophils, and the submucosal glan-
dular density. The intraepithelial lymphocyte counts and
the density of the epithelial and submucosal inflammatory
infiltrate were examined by Periodic acid–Schiff, and the
basal membrane thickening, submucosal edema and fibro-
sis were determined by Masson’s trichrome stain. The
variable counts were determined by analyzing the histo-
logical sections that were randomly selected from the best
embedded glass slides using at least 10 fields per 40×
high-power field. The measurements of the basal mem-
brane were made with the aid of a micrometer eyepiece
graticule (Breslow strip) in histological sections stained
with Masson’s trichrome in 10 high-power fields of 40×
magnification, which were randomly selected areas where
the material was well embedded. The lymphocyte, eosino-
phil, apoptotic body and submucosal gland counts, as well
as the basal membrane thickness values, were summed
and divided by the number of selected fields (arithmetic
average) for a comparative analysis among the groups.
The inflammatory infiltrate density as well as edema and
fibrosis levels were subjectively graded under optical mi-
croscopy as absent, mild, moderate or severe.
For electron microscopy, the sample was placed on a
permeable thin paper card on a hard wax and cut into
fine fragments approximately 0.3 mm in diameter and
then placed in a container with fixative (3% glutaralde-
hyde solution) and maintained at 4°C for 3 hours. The
samples were then processed through the wash stepsand placed in a container with phosphate buffer. Various
fragments of approximately 2 mm from the uncinate
process were randomly selected and made into ultrathin
sections 50 to 60 nm thick using an ultramicrotome dia-
mond knife. The magnification used was 1,600 to
20,000×. The parameters subjectively evaluated by trans-
mission electron microscopy included the following:
amount of cilia (absent, decreased, normal), organization
of ciliary structures, squamous metaplasia (absent or
present), microvilli (present or absent), goblet cells (absent,
decreased, increased or normal), intracellular mitochondria
(present or absent) and cytoplasmic vacuolization (present
or absent). The ciliary orientation was measured by cross-
sections of at least 10 cilia, which were delineated as one
perpendicular line between the central microtubules and
arranged in the same direction and angle within a possible
variation of 10°.
For light microscopy, all of the slides were examined
by two pathologists, and for electron microscopy, all of
the fragments of the biopsy were always evaluated by the
same investigator.
The data collected from the biopsies were compared
among the two groups using a statistical analysis of con-
tingency (chi-squared) and the Wilcoxon test in R ver-
sion 2.7.0 (© 2008 The R Foundation for Statistical
Computing). The level of significance (P value) was set
at 0.05, and confidence intervals were set at 95%.
The data used as a control for comparison and discus-
sion in this study were obtained from our previous stud-
ies, the methodologies of which were identical [11].
These studies evaluated the histological aspects of the
nasal mucosa of immunocompetent patients and pa-
tients undergoing bone marrow transplants, with and
without rhinosinusitis [16,18].
Results
There were no significant changes between the groups
of HSCT patients, with and without rhinosinusitis, in
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lysis by optical microscopy (Table 3). However, the dens-
ity of the inflammatory infiltrate in patients with
rhinosinusitis was moderate in 37% of the patients, com-
pared with no evidence of inflammatory infiltrate in
transplanted patients without rhinosinusitis. The muco-
sal eosinophil and lymphocytes counts were almost 10
times higher in the HSCT patients with rhinosinusitis.




Figure 1 Histological sections of the nasal epithelia of transplanted p
eosinophilic inflammatory infiltrate and submucosal epithelium (hematoxyl
(Periodic acid–Schiff). (E) Ciliated epithelium, pseudostratified without fibro
(G) Thickening of the basement membrane (arrow) in Masson’s trichrome.patients with rhinosinusitis and occurred in none of
those without rhinosinusitis. Figure 1 shows the histo-
logical sections under optical microscopy, comparing the
HSCT patients with and without rhinosinusitis.
Regarding the parameters studied by transmission
electron microscopy, there was a significant difference in
the normal ciliary orientation in the group without rhi-
nosinusitis. There was a trend toward a difference in the




atients under optical microscopy. (A), (B) Intense and moderate
in and eosin). (C), (D) Lymphocytic inflammatory infiltrate epithelium
sis (Masson’s trichrome). (F) Subepithelial (Masson’s trichrome) fibrosis.
(H) Submucosal edema (Hematoxilin and eosin).
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nusitis (Table 4). The primary modifications of the ultra-
structure were the compound cilia and triple central
microtubules. Forty-five percent of the patients with rhi-
nosinusitis had no cilia on the surfaces of the ciliated
cells, whereas the cilia were not absent in the HSCT pa-
tients without rhinosinusitis. Squamous metaplasia oc-
curred in approximately 23% of the patients in the
rhinosinusitis group. Despite there being no significant
difference in the number of goblet cells, approximately
59% of transplanted patients with rhinosinusitis had few
or no goblet cells in the nasal respiratory epithelium.
Further, 55% of transplanted patients with rhinosinusitis
had decreased amounts of cytoplasmic mitochondria.
Figure 2 shows the histological sections of the different
groups under electron microscopy.Discussion
Compared with immunocompetent patients, there is a
higher prevalence of bacterial rhinosinusitis in HSCT
patients; recurrence is 4.3 times higher in HSCT patients
with chronic GVHD [6-8].
A previous study found that hematopoietic stem cell-
transplanted patients experience epithelial injury after
transplantation, showing a reduction in the number of
cilia (77%) and goblet cells (50%) and a 50% change in
the ciliary ultrastructure, independent of sinonasal infec-
tions [16]. These abnormalities would trigger mucous
dryness, malfunctions of mucociliary clearance, and in-
adequate lubrication that prevents the surface mainten-
ance of defense proteins (lysozymes, lactoferrins and
IgA) [19]. This epithelial damage, in addition to the im-
munosuppression inherent in transplantations, may ex-
plain the higher rates of occurrence and recurrence of
rhinosinusitis in these patients.Table 4 Analysis of the nasal epithelium by transmission
electron microscopy
Electron microscopy Without RS With RS P value
Cilia (absence) 0 13 (59%) 0.052
Ultrastructural modification 2 (33%) 5 (50%) 0.054
Normal ciliary orientation 5 (83%) 8 (36%) 0.009
Squamous metaplasia 0 5 (23%) 0.553
Microvilli 5 (83%) 16 (73%) 1
Goblet cells (decreased/absence) 1 (17%) 13 (59%) 0.306
Cytoplasmic mitochondria
(decreased/absence)
1 (17%) 12 (55%) 0.285
Cytoplasmic vacuolization 3 (50%) 10 (45%) 1
Hematopoietic stem cell transplanted patients, with and without rhinosinusitis
(RS). Fisher’s exact test and Wilcoxon analysis with P <0.05 are in bold.Chronic GVHD can affect the mucosal membranes of
transplanted hematopoietic stem cell patients due to a cyto-
toxic reaction that results in the generation of apoptotic
bodies as the end product of cellular degeneration in the
epithelium [20]. Previous studies have shown an increase in
the number of apoptotic bodies in the sinonasal mucosa of
HSCT with chronic GVHD [16]. This result could also ex-
plain the greater risk of rhinosinusitis in these patients, as
described in the literature.
However, a subsequent study showed no difference in
the epithelial damage in HSCT patients, with or without
chronic GVHD, in the presence of rhinosinusitis [18].
The only significant finding of this study was an increase
in the number of microvilli, which may have occurred
due to release of proinflammatory cytokines in the
nasosinal mucosa in chronic rhinosinusitis. These cyto-
kines decrease ciliogenesis and the formation of basal
bodies, preventing the elongation of the centrioles [21].
A transplanted patient with chronic GVHD does not seem
to have more severe epithelial lesions relative to other
HSCT patients, although such a patient would appear to
have more edema and fibrosis. In addition, these patients
appear to have denser inflammatory infiltrate with eosino-
phils and decreased glandular density in the submucosa. It
has been suggested that immunosuppression remains the
main cause of the higher prevalence of rhinosinusitis
among recipients, with or without GVHD [18].
In immunocompetent patients, chronic and/or recur-
rent rhinosinusitis is known to cause histological abnor-
malities in the sinus mucosa, disrupting the protective
barrier and potentially triggering the immune response
of the individual, depending on the pathogen [22]. These
abnormalities may be ultrastructural (17 to 45%), related
to the leukocyte inflammatory infiltrate, the epithelial
squamous metaplasia, the glandular hyperplasia or the
presence of microvilli [22-25]. Aside from these abnor-
malities, aggravating factors – such as anatomical varia-
tions, allergy, smoking and genetic diseases – can
perpetuate sinonasal inflammation or stimulate its recur-
rence [1,2]. A previous study showed that rhinosinusitis
recurrence in HSCT patients is associated with an ab-
sence or decrease in the number of cilia [18]. Rhinosinu-
sitis may thus be an aggravating factor for sinonasal
epithelial damage in these patients.
In this study, rhinosinusitis did not significantly influ-
ence the nasal histology of HSCT patients, although
these patients did show a more dense inflammatory infil-
trate with eosinophils and intraepithelial lymphocytes, as
well as increased edema and fibrosis. These features
seem to result from the modification of the top of the
cilia and the ciliary ultrastructure (50%), which changes
the orientation of the cilia during rhinosinusitis.
The ultrastructural abnormalities found here are






Figure 2 Ciliated nasal epithelium of transplanted patients without and with rhinosinusitis under transmission electron microscopy. (A)
Ciliated cells with a cilia decrease and microvilli increase. (B) Ciliated cells without cilia or mitochondria and with cytoplasmic vacuolization. (C)
Normal ciliated epithelium with goblet cells. (D) Ciliated epithelium without cilia and mononuclear cells migrating to the surface (arrows). (E)
Epithelium with normal cilia. (F) Compound cilia (longitudinal). (G) Compound cilia (*transversal). (H) Squamous metaplasia. Right column,
patients without rhinosinusitis; left column, patients with rhinosinusitis.
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and triple central microtubules, which occur after the re-
lease of cytokines or toxins and proteases from the infect-
ing microorganisms (viruses, bacteria or fungi). These
abnormalities may improve over an approximately 10-
week course of recovery from infection [10,21,26].
Epithelial damage may therefore be a consequence of
the transplant process and an aggravating factor for rhi-
nosinusitis. Rhinosinusitis recurrences can also act as an
aggravating factor for this epithelial damage. Finally, im-
munosuppression is the main causal factor for HSCT
rhinosinusitis and chronic GVHD.
Conclusion
HSCT patients, with and without rhinosinusitis, showed
no significant histological abnormalities, except for cil-
iary disorientation, a possible decrease in the amount of
cilia and an increase in ultrastructural abnormalities in
HSCT patients with rhinosinusitis.
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